What You Should Know:
- Debiopharm, a leading independent biopharmaceutical company, and ThinkingNodeLife.ai (TNL), a pioneer in AI-powered drug discovery, today announced a groundbreaking partnership to propel the development of a cutting-edge cancer drug.
- This strategic partnership combines Debiopharm's deep pharmaceutical expertise with TNL's revolutionary AI Digital Cells Lab platform, unlocking new frontiers in cancer treatment innovation.
Unlocking the Hidden Potential of a
Read More
Artificial Intelligence in Healthcare | News, Analysis, Insights - HIT Consultant
Innovaccer Launches AI Assistant to Reduce Clinical Burden
What You Should Know:
- Innovaccer, a healthcare data platform, unveils Sara Scribe, an AI assistant poised to revolutionize healthcare documentation.
- Sara Scribe, also known as InScribe, transcends the limitations of standard dictation software. This innovative tool uses advanced AI to not only transcribe doctor-patient conversations in real-time but also analyze them and deliver actionable insights, streamlining workflows and freeing up valuable clinician time.
Beyond Transcription:
Read More
Mayo Clinic, Techcyte Partner to Create AI-Powered Pathology Platform
What You Should Know:
- Mayo Clinic Platformv and Techcyte have joined forces to revolutionize the field of pathology by creating a digital pathology platform. This platform aims to pioneer the next generation of pathology services through an open, AI-driven solution, enhancing treatment, efficiency, and accuracy globally.
- By enabling healthcare organizations to economically digitize their pathology practices, the platform integrates innovative technical and AI workflow
Read More
Care Continuity Secures $10M to Turbocharge Patient Navigation
What You Should Know:
- Care Continuity, a leading provider of data-driven patient navigation solutions, has secured $10M in Series A-3 funding, fueling its mission to streamline healthcare journeys and optimize network utilization. The investment, co-led by Empactful Capital & Viewside Capital Partners with participation from Flat Creek Capital and Loop 289 Limited Partners, empowers Care Continuity to further enhance its platform and reach, impacting both providers and patients across
Read More
Amgen Builds Generative AI Models for Human Data Analysis and Drug Discovery
What You Should Know:
- Amgen, a global leader in biotechnology, is embarking on a groundbreaking venture: Project Freyja.
- The new initiative will harness the power of an NVIDIA DGX SuperPOD, christened after the Norse goddess of prediction, to accelerate drug discovery and development through AI-powered insights from one of the world's largest human datasets.
Advance Drug Discovery Using NVIDIA DGX SuperPOD-Powered Insight
Human Diversity Atlas: Freyja will map the landscape
Read More
QuantHealth Scores $17M to Supercharge AI-Driven Clinical Trials
What You Should Know:
- In a decisive move towards faster and more efficient drug development, QuantHealth, a leading AI-powered clinical trial design company, has secured a strategic investment of $17M.
- The new capital, fueled by Accenture Ventures alongside a prominent CRO and additional investors, bolsters QuantHealth's total Series A funding and propels its mission to revolutionize clinical trials through AI simulations.
Saving Millions with 86% Predictive
Read More
GE HealthCare Acquires MIM Software to Enhance Precision Care
What You Should Know:
- In a move poised to reshape the landscape of precision care, GE HealthCare (Nasdaq: GEHC) has announced the acquisition of MIM Software, a provider of medical imaging analysis and AI solutions.
- This strategic acquisition strengthens GE HealthCare's commitment to developing smart, interconnected devices and digital solutions that empower clinicians to deliver more precise, personalized care across various specialties.
Fueling Innovation in Precision
Read More
Deloitte Unveils Atlas AI: Accelerating Drug Discovery with Generative AI and NVIDIA Power
What You Should Know:
- Deloitte, a global leader in professional services, has unveiled Atlas AI, a groundbreaking addition to its Quartz AI™ suite, marking a significant leap forward in life sciences and healthcare (LSHC).
- Built on the NVIDIA AI and NVIDIA Omniverse™ platforms, Atlas AI empowers scientists with novel tools to expedite drug discovery and bring life-saving treatments to market faster.
Harnessing the Power of Generative AI
Atlas AI boasts a unique arsenal of AI
Read More
Breaking Down NLP & Generative AI: How It’s Most Useful to Clinicians Today
Over the last year, the term “Generative AI” has exploded on the healthcare scene, with health and social systems trying to determine if and how they can incorporate the newest tech trend into their day-to-day practice to streamline and improve operations, and ultimately improve patient care.
But most organizations have decided to take a measured approach and see how the hype plays out – they have decided to proceed thoughtfully and with diligence before viewing Generative AI as the panacea
Read More
Mayo Clinic, Aiforia Partner on AI Model for Colorectal Cancer Recurrence
What You Should Know:
- In a groundbreaking collaboration, Aiforia, an AI company specializing in pathology solutions, and Mayo Clinic have announced the exclusive licensing of a revolutionary AI model that improves the prediction of colorectal cancer recurrence.
- The successful development and licensing of this AI model marks a significant milestone in the fight against colorectal cancer. As this technology becomes integrated into clinical practice, it has the potential to transform the
Read More
